IPP Bureau
Amway India launches ‘Beyond Biotin’ Nutrilite Biotin C Plus to support skin, hair, nail health
By IPP Bureau - January 24, 2026
The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc
Yugap Wellness bolsters scientific leadership with Dr Satish Singh appointment
By IPP Bureau - January 24, 2026
A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods
Rising demand for obesity drugs hits employer healthcare budgets, says Howden Report
By IPP Bureau - January 24, 2026
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
Sun Pharma gets DCGI nod to launch generic Semaglutide injection for weight loss in India
By IPP Bureau - January 24, 2026
Company to launch product after the expiry of semaglutide patent in India
Lupin receives highest ESG rating from CDP for climate change and water security
By IPP Bureau - January 24, 2026
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
.jpg "Cipla reports consolidated PAT of Rs. 675.80 Cr")
Cipla reports consolidated PAT of Rs. 675.80 Cr
By IPP Bureau - January 24, 2026
Cipla has reported total income of Rs. 7,280.82 crore during the period ended December 31, 2025
Laurus Labs reports consolidated Q3 net profit of Rs. 251.66 Cr
By IPP Bureau - January 24, 2026
Laurus Labs has reported total income of Rs. 1,784.05 crore during the period ended December 31, 2025
Jagsonpal Pharmaceuticals posts Q3 FY26 profit at Rs. 10.95 Cr
By IPP Bureau - January 24, 2026
Jagsonpal Pharmaceuticals has reported total income of Rs. 75.92 crore during the period ended December 31, 2025
Functional Gut Clinic launches UK’s first boutique GI clinical trials division
By IPP Bureau - January 23, 2026
Gastrointestinal conditions affect millions across the UK, yet research in the field has often been fragmented, slow, or under-resourced
Alteogen strikes $285M deal with GSK subsidiary for innovative cancer drug delivery
By IPP Bureau - January 23, 2026
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
FDA nod to Boehringer Ingelheim's heart disease treatment for dogs 'Vetmedin'
By IPP Bureau - January 23, 2026
VETMEDIN (pimobendan) chewable tablets and VETMEDIN solution (pimobendan oral solution) can delay the onset of congestive heart failure (CHF) in dogs
G Square acquires majority stake in Finnish surgical solutions leader Serres
By IPP Bureau - January 23, 2026
Bayer and Vanderbilt launch five-year partnership to accelerate innovative therapies
By IPP Bureau - January 23, 2026
The partnership initially will focus on cardiovascular and kidney diseases
Dr Reddys Laboratories consolidated Q3 FY26 PAT drops to Rs. 1209.8 Cr, expands global pipeline
By IPP Bureau - January 23, 2026
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
